A single center, crossover, open, prospective study evaluating pharmacokinetic interaction between venetoclax and warfarin in healthy female volunteers.

Trial Profile

A single center, crossover, open, prospective study evaluating pharmacokinetic interaction between venetoclax and warfarin in healthy female volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Dec 2016

At a glance

  • Drugs Venetoclax (Primary) ; Warfarin (Primary)
  • Indications Acute myeloid leukaemia; Breast cancer; Chronic lymphocytic leukaemia; Diffuse large B cell lymphoma; Follicular lymphoma; Multiple myeloma; Myelodysplastic syndromes; Non-Hodgkin's lymphoma; Systemic lupus erythematosus; Thromboembolism; Waldenstrom's macroglobulinaemia
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 08 Dec 2016 New trial record
    • 02 Dec 2016 Results assessing pharmacokinetic interaction between venetoclax and warfarin published in the Clinical Drug Investigation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top